Navegar

Colección

Datos Estadísticas

Artículo

Este artículo es de Acceso Abierto y puede ser descargado en su versión final desde nuestro repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

Background: In assisted reproduction cycles, gonadotropins are administered to obtain a greater number of oocytes. A majority of patients do not have an adverse response; however, approximately 3-6% develop ovarian hyperstimulation syndrome (OHSS). Metformin reduces the risk of OHSS but little is known about the possible effects and mechanisms of action involved. Objective. To evaluate whether metformin attenuates some of the ovarian adverse effects caused by OHSS and to study the mechanisms involved. Material and methods. A rat OHSS model was used to investigate the effects of metformin administration. Ovarian histology and follicle counting were performed in ovarian sections stained with Masson trichrome. Vascular permeability was measured by the release of intravenously injected Evans Blue dye (EB). VEGF levels were measured by commercially immunosorbent assay kit. COX-2 protein expression was evaluated by western blot and NOS levels were analyses by immunohistochemistry. Results: Animals of the OHSS group showed similar physiopathology characteristics to the human syndrome: increased body weight, elevated progesterone and estradiol levels (P<0.001), increased number of corpora lutea (P<0.001), higher ovarian VEGF levels and vascular permeability (P<0.001 and P<0.01); and treatment with metformin prevented this effect (OHSS+M group; P<0.05). The vasoactive factors: COX-2 and NOS were increased in the ovaries of the OHSS group (P<0.05 and P<0.01) and metformin normalized their expression (P<0.05); suggesting that metformin has a role preventing the increased in vascular permeability caused by the syndrome. Conclusion: Metformin has a beneficial effect preventing OHSS by reducing the increase in: body weight, circulating progesterone and estradiol and vascular permeability. These effects of metformin are mediated by inhibiting the increased of the vasoactive molecules: VEGF, COX-2 and partially NOS. Molecules that are increased in OHSS and are responsible for a variety of the symptoms related to OHSS. © 2013 Elia et al.; licensee BioMed Central Ltd.

Registro:

Documento: Artículo
Título:Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study
Autor:Elia, E.M.; Quintana, R.; Carrere, C.; Bazzano, M.V.; Rey-Valzacchi, G.; Paz, D.A.; Pustovrh, M.C.
Filiación:Laboratorio de Biología Del Desarrollo, Facultad de Ciencias Exactas y Naturales, Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE-CONICET-UBA), Buenos Aires, Argentina
Procrearte, Medicina Reproductiva y Molecular, Buenos Aires, Argentina
Departamento de Biodiversidad y Biología Experimental, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina
Departamento de Morfología, Escuela de Ciencias Básicas, Universidad Del Valle, Cali, Colombia
Palabras clave:cyclooxygenase 2; estradiol; Evans blue; metformin; nitric oxide synthase; progesterone; vasculotropin; animal experiment; animal model; article; blood vessel permeability; body weight; controlled study; enzyme linked immunosorbent assay; female; immunohistochemistry; nonhuman; ovary follicle; ovary hyperstimulation; pathophysiology; priority journal; protein expression; rat; Western blotting
Año:2013
Volumen:6
Número:1
DOI: http://dx.doi.org/10.1186/1757-2215-6-62
Título revista:Journal of Ovarian Research
Título revista abreviado:J. Ovarian Res.
ISSN:17572215
CAS:Evans blue, 314-13-6; estradiol, 50-28-2; metformin, 1115-70-4, 657-24-9; nitric oxide synthase, 125978-95-2; progesterone, 57-83-0; vasculotropin, 127464-60-2
PDF:https://bibliotecadigital.exactas.uba.ar/download/paper/paper_17572215_v6_n1_p_Elia.pdf
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_17572215_v6_n1_p_Elia

Referencias:

  • Albert, C., Garrido, N., Mercader, A., Rao, C.V., Remohi, J., Simon, C., Pellicer, A., The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome (2002) Molecular Human Reproduction, 8 (5), pp. 409-418
  • Friedman, C.I., Arbogast, L., Danforth, D.R., Alak, B.M., Herbosa-Encarnacion, C., Seifer, D.B., Follicular fluid vascular endothelial growth factor concentrations are elevated in women of advanced reproductive age undergoing ovulation induction (1997) Fertility and Sterility, 68 (4), pp. 607-612. , DOI 10.1016/S0015-0282(97)00278-1, PII S0015028297002781
  • Manau, D., Fábregues, F., Peñarrubia, J., Creus, M., Carmona, F., Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF (2007) Hum Reprod, 22 (3), pp. 669-675. , 17079244
  • Quintana, R., Kopcow, L., Marconi, G., Young, E., Yovanovich, C., Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model (2008) Fertil Steril, 90 (4), pp. 1511-1516. , 10.1016/j.fertnstert.2007.09.028 18166186
  • Gomez, R., Soares, S.R., Busso, C., Garcia-Velasco, J.A., Simon, C., Physiology and pathology of ovarian hyperstimulation syndrome (2010) Semin Reprod Med, 28 (6), pp. 448-457. , 10.1055/s-0030-1265670 21082502
  • Gomez, R., Ferrero, H., Delgado-Rosas, F., Gaytan, M., Morales, C., Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: Implications for OHSS development and treatment (2011) J Clin Endocrinol Metab, 96 (8), pp. 2484-2492. , 10.1210/jc.2011-0075 21646367
  • Fujii, E., Irie, K., Ohba, K.-I., Ogawa, A., Yoshioka, T., Yamakawa, M., Muraki, T., Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin (1997) Naunyn-Schmiedeberg's Archives of Pharmacology, 356 (4), pp. 475-480. , DOI 10.1007/PL00005079
  • Hester, K.E., Harper, M.J.K., Duffy, D.M., Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primates when administered to simulate emergency contraception (2010) Hum Reprod, 25 (2), pp. 360-367. , 10.1093/humrep/dep424 19965877
  • Jesam, C., Salvatierra, A.M., Schwartz, J.L., Croxatto, H.B., Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: Potential for emergency contraception (2010) Hum Reprod, 25 (2), pp. 368-373. , 10.1093/humrep/dep392 19933235
  • Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Moller, D.E., Role of AMP-activated protein kinase in mechanism of metformin action (2001) Journal of Clinical Investigation, 108 (8), pp. 1167-1174. , DOI 10.1172/JCI200113505
  • Fryer, L.G.D., Parbu-Patel, A., Carling, D., The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways (2002) Journal of Biological Chemistry, 277 (28), pp. 25226-25232. , DOI 10.1074/jbc.M202489200
  • Zou, M.-H., Kirkpatrick, S.S., Davis, B.J., Nelson, J.S., Wiles IV, W.G., Schlattner, U., Neumann, D., Goldman, M.H., Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo: Role of mitochondrial reactive nitrogen species (2004) Journal of Biological Chemistry, 279 (42), pp. 43940-43951. , DOI 10.1074/jbc.M404421200
  • Viollet, B., Guigas, B., Sanz Garcia, N., Leclerc, J., Foretz, M., Cellular and molecular mechanisms of metformin: An overview (2011) Clin Sci (Lond), 122 (6), pp. 253-270
  • Morin-Papunen, L., Rantala, A.S., Unkila-Kallio, L., Tiitinen, A., Hippelainen, M., Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): A multicenter, double-blind, placebo-controlled randomized trial (2012) J Clin Endocrinol Metab, 97 (5), pp. 1492-1500. , 10.1210/jc.2011-3061 22419702
  • Elia, E.M., Pustovrh, C., Amalfi, S., Devoto, L., Motta, A.B., Link between metformin and the peroxisome proliferator-activated receptor γ pathway in the uterine tissue of hyperandrogenized prepubertal mice (2011) Fertil Steril, 95 (8), pp. 2534-2537. , e1 10.1016/j.fertnstert.2011.02.004 21382619
  • Ghazeeri, G.S., Nassar, A.H., Younes, Z., Awwad, J.T., Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: An overview (2012) Acta Obstet Gynecol Scand, 91 (6), pp. 658-678. , 10.1111/j.1600-0412.2012.01385.x 22375613
  • Xiao, J., Chen, S., Zhang, C., Chang, S., The effectiveness of metformin ovulation induction treatment in patients with PCOS: A systematic review and meta-analysis (2012) Gynecol Endocrinol
  • Wei, Z., Cao, Y., Cong, L., Zhou, P., Zhang, Z., Effect of metformin pretreatment on pregnancy outcome of in vitro matured oocytes retrieved from women with polycystic ovary syndrome (2008) Fertil Steril, 90 (4), pp. 1149-1154. , 10.1016/j.fertnstert.2007.07.1385 18022165
  • Elia, E., Sander, V., Luchetti, C.G., Solano, M.E., Di Girolamo, G., Gonzalez, C., Motta, A.B., The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice (2006) Molecular Human Reproduction, 12 (8), pp. 475-481. , DOI 10.1093/molehr/gal057
  • Elia, E.M., Belgorosky, D., Faut, M., Vighi, S., Pustovrh, C., The effects of metformin on uterine tissue of hyperandrogenized BALB/c mice (2009) Mol Hum Reprod, 15 (7), pp. 421-432. , 10.1093/molehr/gap033 19482906
  • Solano, M.E., Elia, E., Luchetti, C.G., Sander, V., Di Girolamo, G., Gonzalez, C., Motta, A.B., Metformin prevents embryonic resorption induced by hyperandrogenisation with dehydroepiandrosterone in mice (2006) Reproduction, Fertility and Development, 18 (5), pp. 533-544. , DOI 10.1071/RD05099
  • Palomba, S., Falbo, A., Carrillo, L., Villani, M.T., Orio, F., Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: A randomized, controlled trial (2011) Fertil Steril, 96 (6), pp. 1384-1390. , e4 10.1016/j.fertnstert.2011.09.020 21982727
  • Ujioka, T., Matsuura, K., Kawano, T., Okamura, H., Role of progesterone in capillary permeability in hyperstimulated rats (1997) Human Reproduction, 12 (8), pp. 1629-1634. , DOI 10.1093/humrep/12.8.1629
  • Saylan, A., Arioz, D.T., Koken, T., Dilek, H., Saylan, F., Prevention of ovarian hyperstimulation syndrome in a rat model: Efficacy comparison between cabergoline and meloxicam (2010) Acta Obstet Gynecol Scand, 89 (5), pp. 692-699. , 10.3109/00016341003592537 20423279
  • Scotti, L., Abramovich, D., Pascuali, N., De Zuniga, I., Oubina, A., Involvement of the ANGPTs/Tie-2 system in ovarian hyperstimulation syndrome (OHSS) (2012) Mol Cell Endocrinol, 365 (2), pp. 223-230. , 23123737
  • Scotti, L., Irusta, G., Abramovich, D., Tesone, M., Parborell, F., Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome (2011) Mol Cell Endocrinol, 335 (2), pp. 116-125. , 10.1016/j.mce.2011.01.002 21238536
  • Kitajima, Y., Endo, T., Nagasawa, K., Manase, K., Honnma, H., Baba, T., Hayashi, T., Saito, T., Hyperstimulation and a gonadotropin-releasing hormone agonist modulate ovarian vascular permeability by altering expression of the tight junction protein claudin-5 (2006) Endocrinology, 147 (2), pp. 694-699. , http://endo.endojournals.org/cgi/reprint/147/2/694, DOI 10.1210/en.2005-0700
  • Woodruff, T.K., D'Agostino, J., Schwartz, N.B., Mayo, K.E., Dynamic changes in inhibin messenger RNAs in rat ovarian follicles during the reproductive cycle (1988) Science, 239 (4845), pp. 1296-1299. , 10.1126/science.3125611 3125611
  • Cheng, G., Weihua, Z., Makinen, S., Makela, S., Saji, S., Warner, M., Gustafsson, J.-A., Hovatta, O., A role for the androgen receptor in follicular atresia of estrogen receptor beta knockout mouse ovary (2002) Biology of Reproduction, 66 (1), pp. 77-84
  • Hu, Y.-C., Wang, P.-H., Yeh, S., Wang, R.-S., Xie, C., Xu, Q., Zhou, X., Chang, C., Subfertility and defective folliculogenesis in female mice lacking androgen receptor (2004) Proceedings of the National Academy of Sciences of the United States of America, 101 (31), pp. 11209-11214. , DOI 10.1073/pnas.0404372101
  • D'Angelo, A., Amso, N., Embryo freezing for preventing ovarian hyperstimulation syndrome (2007) Cochrane Database Syst Rev, 3, pp. 3D002806. , 17636707
  • Isikoglu, M., Berkkanoglu, M., Senturk, Z., Ozgur, K., Human albumin does not prevent ovarian hyperstimulation syndrome in assisted reproductive technology program: A prospective randomized placebo-controlled double blind study (2007) Fertility and Sterility, 88 (4), pp. 982-985. , DOI 10.1016/j.fertnstert.2006.11.170, PII S0015028206047170
  • Engmann, L., Diluigi, A., Schmidt, D., Nulsen, J., Maier, D., The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: A prospective randomized controlled study (2008) Fertil Steril, 89 (1), pp. 84-91. , Epub 2007 Apr 26 10.1016/j.fertnstert.2007.02.002 17462639
  • Busso, C., Fernandez-Sanchez, M., Garcia-Velasco, J.A., Landeras, J., Ballesteros, A., The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: A randomized, double-blind, placebo-controlled trial (2010) Hum Reprod, 25 (4), pp. 995-1004. , doi:10.1093/humrep/deq005. Epub 2010 Feb 6 10.1093/humrep/deq005 20139430
  • Lainas, T.G., Sfontouris, I.A., Zorzovilis, I.Z., Petsas, G.K., Lainas, G.T., Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: A prospective randomised controlled trial (RCT) (2010) Hum Reprod, 25 (3), pp. 683-689. , doi:10.1093/humrep/dep436Epub. 2009 Dec 15 10.1093/humrep/dep436 20008886
  • Varnagy, A., Bodis, J., Manfai, Z., Wilhelm, F., Busznyak, C., Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome (2010) Fertil Steril, 93 (7), pp. 2281-2284. , doi:10.1016/j.fertnstert.2009.01.085. Epub 2009 Mar 3 10.1016/j.fertnstert.2009.01.085 19261278
  • Tang, T., Glanville, J., Orsi, N., Barth, J.H., Balen, A.H., The use of metformin for women with PCOS undergoing IVF treatment (2006) Human Reproduction, 21 (6), pp. 1416-1425. , DOI 10.1093/humrep/del025
  • Palomba, S., Falbo, A., Orio Jr., F., Manguso, F., Russo, T., Tolino, A., Colao, A., Zullo, F., A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination (2005) Human Reproduction, 20 (10), pp. 2879-2886. , DOI 10.1093/humrep/dei130
  • Meldrum, D.R., Chang, R.J., De-Ziegler, D., Schoolcraft, W.B., Scott Jr., R.T., Adjuncts for ovarian stimulation: When do we adopt orphan indications for approved drugs? (2009) Fertil Steril, 92 (1), pp. 13-18. , doi:10.1016/j.fertnstert.2009.03.081. Epub 2009 May 6 10.1016/j.fertnstert.2009.03.081 19423104
  • Palomba, S., Falbo, A., La-Sala, G.B., Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: A systematic review and meta-analysis of randomised controlled trials (2013) BJOG, 120 (3), pp. 267-276. , 10.1111/1471-0528.12070 23194199
  • De Leo, V., Marca, A.L., Ditto, A., Morgante, G., Cianci, A., Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome (1999) Fertility and Sterility, 72 (2), pp. 282-285. , DOI 10.1016/S0015-0282(99)00208-3, PII S0015028299002083
  • Gomez, R., Simon, C., Remohi, J., Pellicer, A., Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability (2003) Biology of Reproduction, 68 (6), pp. 2164-2171. , DOI 10.1095/biolreprod.102.010801
  • Ozcakir, H.T., Giray, S.G., Ozbilgin, M.K., Inceboz, U.S., Caglar, H., Effect of angiotensin-converting enzyme-inhibiting therapy on the expression of vascular endothelial growth factor in hyperstimulated rat ovary (2004) Fertility and Sterility, 82 (SUPPL. 3), pp. 1127-1132. , DOI 10.1016/j.fertnstert.2004.03.053, PII S0015028204012956
  • Lee, A., Burry, K.A., Christenson, L.K., Patton, P.E., Stouffer, R.L., Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization (1997) Fertility and Sterility, 68 (2), pp. 305-311. , DOI 10.1016/S0015-0282(97)81520-8, PII S0015028297002057
  • Haghighi Poodeh, S., Salonurmi, T., Nagy, I., Koivunen, P., Vuoristo, J., Alcohol-induced premature permeability in mouse placenta-yolk sac barriers in vivo (2012) Placenta, 10, pp. 866-873
  • Sun, Z., Li, X., Massena, S., Kutschera, S., Padhan, N., VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd (2012) J Exp Med, 209 (7), pp. 1363-1377. , 10.1084/jem.20111343 22689825
  • Solskov, L., Lofgren, B., Kristiansen, S.B., Jessen, N., Pold, R., Nielsen, T.T., Botker, H.E., Lund, S., Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration (2008) Basic and Clinical Pharmacology and Toxicology, 103 (1), pp. 82-87. , DOI 10.1111/j.1742-7843.2008.00234.x
  • Cianchi, F., Cortesini, C., Fantappie, O., Messerini, L., Sardi, I., Lasagna, N., Perna, F., Masini, E., Cyclooxygenase-2 Activation Mediates the Proangiogenic Effect of Nitric Oxide in Colorectal Cancer (2004) Clinical Cancer Research, 10 (8), pp. 2694-2704. , DOI 10.1158/1078-0432.CCR-03-0192
  • Wu, A.-W., Gu, J., Li, Z.-F., Ji, J.-F., Xu, G.-W., COX-2 expression and tumor angiogenesis in colorectal cancer (2004) World Journal of Gastroenterology, 10 (16), pp. 2323-2326
  • Toomey, D.P., Murphy, J.F., Conlon, K.C., COX-2, VEGF and tumour angiogenesis (2009) Surgeon, 7 (3), pp. 174-180. , 10.1016/S1479-666X(09)80042-5 19580182
  • Rattan, R., Graham, R.P., Maguire, J.L., Giri, S., Shridhar, V., Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo (2011) Neoplasia, 13 (5), pp. 483-491. , 21532889
  • Ersoy, C., Kiyici, S., Budak, F., Oral, B., Guclu, M., The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients (2008) Diabetes Res Clin Pract, 81 (1), pp. 56-60. , doi:10.1016/j.diabres.2008.02.006 pub 2008 Mar 21 10.1016/j.diabres.2008. 02.006 18358555
  • Zhang, J., Zhang, Z., Wu, Y., Chen, L., Luo, Q., Regulatory effect of hypoxia-inducible factor-1alpha on hCG-stimulated endothelin-2 expression in granulosa cells from the PMSG-treated rat ovary (2012) J Reprod Dev, 58 (6), pp. 678-684. , Epub 2012 Aug 20 10.1262/jrd.2012-089 22972036
  • Hellwig-Burgel, T., Stiehl, D.P., Wagner, A.E., Metzen, E., Jelkmann, W., Hypoxia-inducible factor-1 (HIF-1): A novel transcription factor in immune reactions (2005) Journal of Interferon and Cytokine Research, 25 (6), pp. 297-310. , DOI 10.1089/jir.2005.25.297

Citas:

---------- APA ----------
Elia, E.M., Quintana, R., Carrere, C., Bazzano, M.V., Rey-Valzacchi, G., Paz, D.A. & Pustovrh, M.C. (2013) . Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study. Journal of Ovarian Research, 6(1).
http://dx.doi.org/10.1186/1757-2215-6-62
---------- CHICAGO ----------
Elia, E.M., Quintana, R., Carrere, C., Bazzano, M.V., Rey-Valzacchi, G., Paz, D.A., et al. "Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study" . Journal of Ovarian Research 6, no. 1 (2013).
http://dx.doi.org/10.1186/1757-2215-6-62
---------- MLA ----------
Elia, E.M., Quintana, R., Carrere, C., Bazzano, M.V., Rey-Valzacchi, G., Paz, D.A., et al. "Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study" . Journal of Ovarian Research, vol. 6, no. 1, 2013.
http://dx.doi.org/10.1186/1757-2215-6-62
---------- VANCOUVER ----------
Elia, E.M., Quintana, R., Carrere, C., Bazzano, M.V., Rey-Valzacchi, G., Paz, D.A., et al. Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study. J. Ovarian Res. 2013;6(1).
http://dx.doi.org/10.1186/1757-2215-6-62